AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

Plus 6,743 TCM formulas connecting herbs together
⚗️ Ingredient

Glutamine

4
Clinical Trials
40
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT05371184
Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients
Completed · Phase 4
NCT05255328
Clinical Long Term Evaluation of Glutamine Supplement in MELAS Syndrome
Active_Not_Recruiting
NCT05856188
Efficacy of Glutamine in Management of Radiation Mucositis
Recruiting
📊 Sample Meta-Analyses
CRD42016038438
Glutamine supplementation in athletes performance, body composition and immune function: a systematic review and meta-analysis of randomized clinical trials
We want to know effect of GLN use for enhancing athletics performance.
CRD42017060384
Effects of glutamine supplementation on critically ill patients: an umbrella review
CRD42018090829
Effect of glutamine on metabolic variables in patients with type 2 diabetes: a systematic review
Type 2 diabetes (T2D) is primarily a problem of progressively impaired glucose r
📚 Sample References
None linked yet.
⚗️ All Ingredient data fields for Glutamine
⚗️ Identity
Name
Glutamine
Aliases / Synonyms
L-glutamine; 56-85-9; Levoglutamide; L-(+)-Glutamine; Glutamic acid amide; Cebrogen; Stimulina; glumin; Levoglutamid
🧪 Chemistry
Molecular Weight
146.1460
LogP
-1.3362
Drug-likeness
0.456
H-Bond Acceptors
3
H-Bond Donors
3
Rotatable Bonds
4
🔬 Structures
Canonical SMILES
C(CC(=O)N)C(C(=O)O)N
Isomeric SMILES
C(CC(=O)N)[C@@H](C(=O)O)N
InChIKey
ZDXPYRJPNDTMRX-VKHMYHEASA-N
InChI
InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1
🔗 External References
PubChem CID
TCMID
32918
🔍 Raw view — every non-empty column on this row (27 fields)
name
Glutamine
common names
L-glutamine; 56-85-9; Levoglutamide; L-(+)-Glutamine; Glutamic acid amide; Cebrogen; Stimulina; glumin; Levoglutamid
herb ingredient id
HBIN028057
canonical smiles
C(CC(=O)N)C(C(=O)O)N
isomeric smiles
C(CC(=O)N)[C@@H](C(=O)O)N
inchi
InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1
inchikey
ZDXPYRJPNDTMRX-VKHMYHEASA-N
mol wt
146.1460
num h acceptors
3
num h donors
3
mol logp
-1.3362
num rotatable bonds
4
drug likeness
0.456
tcmid ingredient id
32918
pubchem cid
5961

🏥 Linked Health Topics

1 · diseases via target pathways

📋 Clinical Trials

4 · subject of clinical study
NCT05371184 Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients
→ Sickle Cell Disease
NCT05255328 Clinical Long Term Evaluation of Glutamine Supplement in MELAS Syndrome
→ MELAS Syndrome
NCT05856188 Efficacy of Glutamine in Management of Radiation Mucositis
→ Radiation-Induced Mucositis
NCT06027242 Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy
→ Gastric Cancer|Immunonutrition|Gastrostomy

📊 Meta-Analyses

12 · systematic review
CRD42016038438 Glutamine supplementation in athletes performance, body composition and immune f
→ We want to know effect of GLN use for enhancing at
CRD42017060384 Effects of glutamine supplementation on critically ill patients: an umbrella rev
CRD42018090829 Effect of glutamine on metabolic variables in patients with type 2 diabetes: a s
→ Type 2 diabetes (T2D) is primarily a problem of pr
CRD42018103582 Role of glutamine supplementation in prevention or treatment of bronchopulmonary
→ Bronchopulmonary dysplasia (BPD) is associated wit
CRD42018107310 L-glutamine for preventing painful vaso-occlusive crises in patients with sickle
→ Sickle cell disease (SCD) is an inherited conditio
CRD42018109628 Efficacy and safety of glutamine supplements for patients with diarrhea-predomin
→ Irritable bowel syndrome with diarrhea (IBS-D) is
CRD42019118405 The effect of glutamine supplementation on exercise-related intestinal permeabil
→ Supplementation of glutamine. Exercise-related int
CRD42019139093 Is oral glutamine really effective to prevent radiation-induced oral mucositis i
→ Head and neck cancer is the eighth most common can
CRD42020155463 Crizanlizumab, Voxelotor, and L-Glutamine for Sickle Cell Disease: Effectiveness
→ Sickle Cell Disease
CRD42020157583 Is glutamine effective to head and neck cancer therapy-related severe mucositis
→ Radiotherapy or concurrent chemoradiotherapy has l
CRD42020163149 A systematic review to determine the cost, probability of developing a complicat
→ Sickle cell disease (SCD) is a genetic disease con
CRD42020191874 Systematic review and meta-analysis of perioperative intravenous glutamine suppl
→ Gastrointestinal malignancies patients following e
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: ACTIVE — direct link via herb_ingredients
  • Ingredient ↔ Target: ACTIVE — direct link via ingredient_targets
  • Target ↔ Disease: ACTIVE — direct link via target_health_topics
  • Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables